The US is the bigger Pathology Imaging Systems market: $680 Mn against $130 Mn in 2023, about 5.2 times as large.
China grows faster: 13.4% a year, against 9.9%. The gap still grows from $550 Mn to $1.3 Bn by 2033.
Clinical research: 563 active trials in the US, 203 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $680 Mn | $130 Mn |
| Market size, 2033 projected | $1.7 Bn | $458 Mn |
| Growth a year (CAGR) | 9.9% | 13.4% |
| Money added, 2023–2033 | $1.1 Bn | $328 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $1.99 | $0.09 |
| Active clinical trials | 563 | 203 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Pathology Imaging Systems, US or China?
The US is the bigger Pathology Imaging Systems market: $680 Mn against $130 Mn in 2023, about 5.2 times as large.
Which grows faster in Pathology Imaging Systems, US or China?
China grows faster: 13.4% a year, against 9.9%. The gap still grows from $550 Mn to $1.3 Bn by 2033.
More Pathology Imaging Systems comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.